Russian sovereign fund RDIF on June 17 declared its COVID-19 vaccine Sputnik V would soon offer a booster shot, adjusted to work against the Delta variant of coronavirus, to other vaccine manufacturers.
In a tweet, the company said: “#SputnikV will soon offer a booster shot, adjusted to work against the Delta variant of Coronavirus, first detected in India, to other vaccine manufacturers.” It then went on to clarify Sputnik V’s role in developing vaccine cocktails.
“Sputnik V is more efficient against the Delta variant of coronavirus first detected in India, than any other vaccine that published
results on this strain so far – the Gamaleya Centre study submitted for publication in an international peer-reviewed journal,” the makers stated further.
RDIF also proclaimed that it would be introducing a single dose Sputnik Light vaccine which would be based on the Ad26 vector in India.
B.1.617.2 or Delta variant first perceived in India, has now emerged as a variant of concern worldwide - potentially reducing the effectiveness of vaccines
Nasal Vaccine for children
In additional tweet, it quotes reports to say: “Russia has tested a nasal spray form of its Covid-19 vaccine that is suitable for children aged 8-12, and plans to launch the new product in September – #SputnikV developer and head of the Gamaleya Center Alexander Gintsburg.”
Prior this month, the Drugs Controller General of India (DCGI) granted permission to Serum Institute of India (SII) to manufacture the Russian Covid-19 vaccine - Sputnik V in India. The drug controller has permitted SII to make Sputnik-V jabs for examination, test, and analysis.
Dr Reddy’s Laboratories, is based in Hyderabad, is Sputnik V’s distributor in India. Previous on Thursday, it was proclaimed that the vaccine would be available in nine more cities, including Delhi, Mumbai, Bengaluru, Kolkata and Chennai.
